Compare American Well Corp (AMWL) vs Infosys Limited (INFY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs Infosys Limited — how do they compare? American Well Corp trades at $9.89 (market cap $165.58M), while Infosys Limited trades at $11.19 (market cap $45.83B). The key difference: Infosys Limited is far larger — about 276.8× American Well Corp's market cap, and Infosys Limited pays a 4.79% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | INFY | |
|---|---|---|
Market Cap | $165.58M | $45.83B |
Sector | Health | Technology |
52-Week High | $9.91 | $20.22 |
52-Week Low | $3.78 | $10.49 |
Enterprise Value | -$9.66M | $43.05B |
Dividend Yield | — | 4.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
INFY trades at $10.94, down 1.71% for the day, with technical indicators showing a bearish trend. The company maintains strong profitability with 16.44% net margins and 31.57% ROE, though recent earnings show mixed results with one miss and two beats. Recent news highlights INFY's aggressive AI partnerships across healthcare, banking, and media sectors, positioning the company for digital transformation leadership.
The stock presents a valuation opportunity with P/E of 13.68 below industry averages, supported by analyst consensus target of $12.14 (11% upside). Key risks include competitive pressures in IT services and potential margin compression from AI investments. Current institutional sentiment leans neutral with 52.5% hold ratings amid transitional business focus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
